Diagnosis at the molecular level
Advanced genomic and molecular testing characterizes a disease — particularly cancer — beyond what conventional pathology shows, revealing the specific mutations and markers that drive it.
Targeted, personalized therapy
Those insights guide targeted therapies, immunotherapy and theranostics — such as Lutetium-177 — that act on a tumor's specific biology, helping match each patient to the most appropriate treatment.
Decisions made by a team
Molecular tumor boards bring together oncologists, pathologists, radiologists and geneticists to translate complex data into a clear, individualized plan.